CYC vs GSS

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

CYC

CYCLOPHARM FPO [CYC]

41LOW

GSS

GENETICSIG FPO [GSS]

54MEDIUM

Score Breakdown

CYC GSS
Technical
41
50
Catalyst
51
65
Sentiment
50
50
Fundamental
69
59
Momentum
39
31
Risk Gate
50
50

Key Metrics

CYC Metric GSS
$61.6MMarket Cap$14.5M
345KAvg Volume (20d)877K
N/AShort InterestN/A
$1.29052-Week High$0.430
$0.45052-Week Low$0.057
-6.7%Daily Change-1.6%
$0.490Reference Price$0.063
-49.3%ROE-22.8%
-53.3%Profit Margin-56.5%

Active Signals

CYC Signals

●RSI drifting toward oversold territory — worth watching
●Volume surging at 2.7x normal while price falls — heavy selling pressure
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.5 quarters)
●Low P/S ratio (1.9x)
●Moderate revenue growth (+10%)
●EPS estimates revised upward (+10pts)

GSS Signals

●RSI drifting toward oversold territory — worth watching
●Trading below both moving averages — the trend is working against this one
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (12 quarters)
●Low P/S ratio (0.7x)
●EPS estimates revised downward (-10pts)
●Near 52-week low (2% of range)

Ask Scout AI to compare CYC and GSS in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

CYC vs IBX →CYC vs IMR →CYC vs MVF →CYC vs NEU →CYC vs PHX →
CYC Full Analysis → GSS Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).